0.11
Impact Factor
0.07
5-Years IF
3
5-Years H index
Consulting Reports / Office of Health Economics
[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [
trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
Main indicators
Raw data
| IF | AIF | IF5 | DOC | CDO | CCU | CIF | CIT | D2Y | C2Y | D5Y | C5Y | %SC | CiY | II | AII | |
| 1990 | 0.11 | 0 | 0 | 0 | (%) | 0.06 | ||||||||||
| 1991 | 0.1 | 0 | 0 | 0 | (%) | 0.04 | ||||||||||
| 1992 | 0.1 | 0 | 0 | 0 | (%) | 0.05 | ||||||||||
| 1993 | 0.13 | 0 | 0 | 0 | (%) | 0.06 | ||||||||||
| 1994 | 0.14 | 0 | 0 | 0 | (%) | 0.06 | ||||||||||
| 1995 | 0.17 | 0 | 0 | 0 | (%) | 0.1 | ||||||||||
| 1996 | 0.22 | 0 | 0 | 0 | (%) | 0.09 | ||||||||||
| 1997 | 0.22 | 0 | 0 | 0 | (%) | 0.09 | ||||||||||
| 1998 | 0.24 | 0 | 0 | 0 | (%) | 0.12 | ||||||||||
| 1999 | 0.3 | 0 | 0 | 0 | (%) | 0.15 | ||||||||||
| 2000 | 0.36 | 0 | 0 | 0 | (%) | 0.14 | ||||||||||
| 2001 | 0.36 | 0 | 0 | 0 | (%) | 0.16 | ||||||||||
| 2002 | 0.37 | 0 | 0 | 0 | (%) | 0.18 | ||||||||||
| 2003 | 0.39 | 0 | 0 | 0 | (%) | 0.19 | ||||||||||
| 2004 | 0.4 | 0 | 0 | 0 | (%) | 0.18 | ||||||||||
| 2005 | 0.42 | 1 | 1 | 0 | 0 | (%) | 0.2 | |||||||||
| 2006 | 0.45 | 1 | 2 | 1 | 1 | (%) | 0.19 | |||||||||
| 2007 | 0.38 | 2 | 2 | 2 | (%) | 0.16 | ||||||||||
| 2008 | 0.39 | 1 | 3 | 1 | 1 | 2 | (%) | 0.17 | ||||||||
| 2009 | 0.36 | 2 | 5 | 1 | 3 | (%) | 0.17 | |||||||||
| 2010 |  0.33 | 0.34 | 0.2 | 4 | 9 | 1 | 0.11 | 1 | 3 | 1 | 5 | 1 | (%) | 0.15 | ||
| 2011 | 0.4 | 3 | 12 | 4 | 6 | 8 | 1 (25%) | 0.19 | ||||||||
| 2012 | 0.44 | 3 | 15 | 1 | 7 | 10 | (%) | 0.2 | ||||||||
| 2013 | 0.17 | 0.49 | 0.08 | 15 | 1 | 0.07 | 6 | 1 | 13 | 1 | (%) | 0.2 | ||||
| 2014 | 0.52 | 0.08 | 3 | 18 | 1 | 0.06 | 4 | 3 | 12 | 1 | 1 (25%) | 0.23 | ||||
| 2015 |  1 | 0.54 | 0.23 | 5 | 23 | 4 | 0.17 | 4 | 3 | 3 | 13 | 3 | (%) | 1 | 0.2 | 0.24 |
| 2016 | 0.6 | 0.07 | 4 | 27 | 1 | 0.04 | 1 | 8 | 14 | 1 | (%) | 0.27 | ||||
| 2017 | 0.11 | 0.64 | 0.07 | 7 | 34 | 5 | 0.15 | 3 | 9 | 1 | 15 | 1 | 1 (33.3%) | 1 | 0.14 | 0.28 |
| IF: | Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for series in RePEc in year y |
| IF5: | Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CCU: | Cumulative number of citations to papers published until year y |
| CIF: | Cumulative impact factor |
| CIT: | Number of citations to papers published in year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series:
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2011 | The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Garrison, L ; Hawe, E ; Devlin, N. In: Consulting Reports. RePEc:ohe:conrep:000192. Full description at Econpapers || Download paper | 4 |
| 2 | 2014 | The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Rejon-Parrilla, J C ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:000050. Full description at Econpapers || Download paper | 3 |
| 3 | 2015 | Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Cole, Amanda ; Barnsley, P ; Devlin, N ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576. Full description at Econpapers || Download paper | 3 |
| 4 | 2017 | Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784. Full description at Econpapers || Download paper | 1 |
| 5 | 2008 | Medical Research: Whats It Worth?. (2008). Of, Office ; Europe, Rand. In: Consulting Reports. RePEc:ohe:conrep:000236. Full description at Econpapers || Download paper | 1 |
| 6 | 2016 | Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. (2016). Towse, Adrian ; Karlsberg, Sarah ; Cubi-Molla, Patricia ; Devlin, N ; Schaffer, Karlsberg S. In: Consulting Reports. RePEc:ohe:conrep:001699. Full description at Econpapers || Download paper | 1 |
| 7 | 2010 | Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe. (2010). Towse, Adrian ; Mestre-Ferrandiz, J ; Puig-Peiro, R. In: Consulting Reports. RePEc:ohe:conrep:000212. Full description at Econpapers || Download paper | 1 |
| 8 | 2018 | The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Cole, Amanda ; Zamora, B ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009. Full description at Econpapers || Download paper | 1 |
| 9 | 2015 | Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK. (2015). Karlsberg, Sarah ; Cole, Amanda ; Schaffer, Karlsberg S ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001595. Full description at Econpapers || Download paper | 1 |
| 10 | 2017 | Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market. (2017). Lorgelly, Paula ; Hampson, Grace ; Berdud, Mikel ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001933. Full description at Econpapers || Download paper | 1 |
| 11 | 2012 | The Many Faces of Innovation. (2012). Mestre-Ferrandiz, J ; Sussex, J ; Mordoh, A. In: Consulting Reports. RePEc:ohe:conrep:000154. Full description at Econpapers || Download paper | 1 |
| 12 | 2017 | Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries. (2017). Garau, Martina ; Zamora, B ; Mestre-Ferrandiz, J ; O'Neill, P ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001818. Full description at Econpapers || Download paper | 1 |
| 13 | 2014 | The Trajectory of Dementia in the UK - Making a Difference. (2014). O'Neill, Phill ; Karlsberg, Sarah ; Cockcroft, L ; Sussex, J ; Schaffer, Karlsberg S ; Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:000518. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2015 | Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Cole, Amanda ; Barnsley, P ; Devlin, N ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576. Full description at Econpapers || Download paper | 3 |
| 2 | 2011 | The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Garrison, L ; Hawe, E ; Devlin, N. In: Consulting Reports. RePEc:ohe:conrep:000192. Full description at Econpapers || Download paper | 3 |
Citing documents used to compute impact factor 1:
| Year | Title | |
|---|---|---|
| 2017 | Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7. Full description at Econpapers || Download paper |
Recent citations (cites in year: CiY)
Recent citations received in 2017
| Year | Citing document | |
|---|---|---|
| 2017 | Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study. (2017). Garau, Martina ; Hernandez-Villafuerte, K ; Garrison, L ; Towse, T. In: Consulting Reports. RePEc:ohe:conrep:001781. Full description at Econpapers || Download paper |
Recent citations received in 2015
| Year | Citing document | |
|---|---|---|
| 2015 | Multi-indication Pricing: Pros, Cons and Applicability to the UK. (2015). Towse, Adrian ; Mestre-Ferrandiz, J ; Pistollato, M ; Dellamano, R. In: Seminar Briefings. RePEc:ohe:sembri:001653. Full description at Econpapers || Download paper |
Recent citations received in 2014
| Year | Citing document |
|---|
10 most frequent citing series
Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.
Source data used to compute the impact factor of RePEc series.
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 2th 2018. Contact: CitEc Team